Bird Flu Monitor > Novartis obtains CHMP positive opinion for its investigational pre ...

[PharmaNews.eu] Novartis announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Aflunov®, an investigational pre-pandemic avian influenza vaccine. The CHMP is endorsing the approval of Aflunov for active immunization against H5N1 subtype of Influenza A virus in adults 18 years of age and older.

Previous [Previous] Avian Influenza (Bird Flu), Fact or Fiction? | influen...

Next [Next] Tembilahan, Riau ::: Possible bird flu suspect « Bird Flu...

Some related posts from Technorati and Google.

[The Bird Flu Report] Novartis obtains CHMP positive opinion for its investigational pre ...: Novartis announced today that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Aflunov®, an investigational pre-pandemic avian influenza vaccine. The CHMP is endorsing the approval of Aflunov for active immunization against H5N1 subtype of Influenza A virus in adults 18 years of age and older.

[Daniels NetWorth] Novartis Obtains CHMP Positive Opinion for its Investigational Pre ...: Novartis announced today that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Aflunov®.

[PeoplesPaging] Novartis obtains CHMP positive opinion for its investigational pre ...: Novartis International AG / Novartis obtains CHMP positive opinion for its investigational pre-pandemic influenza vaccine Aflunov® to help protect against (H5N1) avian influenza processed and transmitted by Hugin AS.

[The Science and Technology Blog] The Science and Technology Blog » Blog Archive » Novartis obtains ...: Thus, proactive pre-pandemic vaccination to prime populations at risk or vaccine stockpiling may be a more adequate way to help protect those at risk of H5N1 infection[12], those who would form the first line of response during a potential pandemic, such as healthcare and emergency workers, and those critical to maintaining business and economic continuity.

[The NewsMarket (All News)] Novartis Obtains CHMP Positive Opinion for its Investigational Pre ...: Novartis announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Aflunov®.

[Brinvest.ch] Novartis International AG: Novartis obtains CHMP positive opinion ...: Novartis International AG / Novartis obtains CHMP positive opinion for its investigational pre-pandemic influenza vaccine Aflunov® to help protect aga

[The Swine Flu Report] Flu watchdog warns against post pandemic complacency: While the global picture was sufficiently like seasonal influenza to allow WHO to declare that the world is in a post pandemic phase that does not mean that everywhere in Europe there will be a benign 2010-2011 season. We do not know what the pattern of the ”˜new’ seasonal influenza will be especially the picture of who the risk groups are (2,3).

[Acne Free System] How To Get Rid Of Acne Using Natural Products: The Science and Technology Blog » Blog Archive » Novartis obtains CHMP positive opinion for its investigational pre-pandemic influenza vaccine Aflunov® to help protect against (H5N1) avian influenza; Podcast 98: Leafy green .

[SpywareDoctorScan] SpywareDoctorScan » Blog Archive » Being Gay and HIV-Positive in ...: Novartis announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Aflunov®, an investigational pre-pandemic avian influenza vaccine. The CHMP is endorsing the approval of Aflunov for active immunization against H5N1 subtype of Influenza A virus in adults 18 years of age and older.

[Life Sciences Blog] NOVARTIS INVESTIGATIONAL ADJUVANTED MF59 PRE-PANDEMIC AVIAN ...: After the first dose of adjuvanted pre-pandemic vaccine, HI results demonstrated that two Committee for Medicinal Products for Human Use (CHMP) criteria were reached by the adolescent group and one was reached by the toddler and .

[lifeinthemixtalk.com] lifeinthemixtalk.com » Blog Archive » EU Approval Granted To ...: The H5N1 clade 2 bulk material is being manufactured from a laboratory version seed virus of the wild-type virus provided by the U.S. Centers for Disease Control and Prevention (CDC). The reference virus, A/Vietnam/1194/2004 (H5N1) NIBRG-14, was developed using reverse genetics, with reassortment strain combining the H5 and N1 segments to with an influenza virus PR8 strain backbone.

Reflected tags on Technorati: Blog, ,